Guillain-Barré Syndrome Following the First Dose of Inactivated SARS-CoV-2 Vaccine, BBIBP-CorV

We present a case report of Guillain-Barré syndrome (GBS) following inactivated whole virus severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccine, BBIBP-CorV. A man presented with paresthesia in both upper and lower limbs with bifacial weakness, onset 18 days after receiving the first...

Descripción completa

Detalles Bibliográficos
Autores principales: Wijekoon, Lanka, Sarathchandra, Chamara, Siribaddana, Sisira
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2023
Materias:
Neurology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9937680/
https://www.ncbi.nlm.nih.gov/pubmed/36819409
http://dx.doi.org/10.7759/cureus.33952

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9937680/
https://www.ncbi.nlm.nih.gov/pubmed/36819409
http://dx.doi.org/10.7759/cureus.33952

Ejemplares similares